Dr. Baeten is Vice Chair and Professor in the Department of Global Health at the University of Washington, where he is also Professor of Medicine and Epidemiology. His research focuses on the prevention of HIV-1 and other sexually transmitted diseases, including clinical trials of novel prevention interventions, epidemiologic studies of risk factors for HIV-1 transmission, and behavioral, translational, and implementation science research aimed at optimizing prevention delivery. He led the Partners PrEP Study and MTN-020/ASPIRE, randomized clinical trials that demonstrated the efficacy of oral tenofovir-based pre-exposure prophylaxis (PrEP) and the dapivirine vaginal ring for protection against HIV-1 acquisition. Current projects include a) a multinational open-label trial of the dapivirine vaginal ring for HIV-1 prevention in women (MTN-025/HOPE, through the NIH Microbicides Trials Network), b) implementation science work to deliver antiretroviral treatment and PrEP for HIV-1 prevention, c) studies exploring use of hormonal contraception as a risk factor for HIV-1 (including co-chairing the ECHO Study), and d) collaborative studies of immunologic and virologic factors that influence HIV-1 transmission.
